Current Issue
Application of Quality Risk Management to Process Validation
Robert Dream, Managing Director, HDR Company LLC
A Holistic Phase Appropriate Strategy for HCP-Limits and HCP Characterization
Dr. Markus Haindl, Global Head Gene Therapy Technical Research & Development, Roche Di...
Strategies for Extractable and Leachable Risk Assessment of Polymeric Single Use Systems U...
Ping Wang, Director, Johnson & Johnson
Use of Non-Contact Raman Spectroscopy to Derive Reaction Kinetics
Richard Hart, Senior Director – Head of Automation and Data Science (Previously Asso...
Amsphere A3
JSR Life Sciences
Featured Articles
Productivity and Economic Advantages of Coupling Single-Pass Tangential Flow Filtration to Multi-Column Chromatography for Continuous Processing
Mark Schofield, Ph.D., Karl Rogler, Xhorxhi Gjoka, Engin Ayturk, Ph.D., and René Gantier, Ph.D.
Process Analytical Technology For Upstream Bioprocessing
Erica Fratz-Berilla and Cyrus Agarabi, FDA CDER
Benefits of Mixed-Mode Cation Exchange Chromatography: CMM HyperCel™ Sorbent Used for Monoclonal Antibody and Other Recombinant Protein Purification
Bringing the Freezing of Biopharmaceuticals in From the Cold
View All Featured ArticlesHeadline News
Zura Bio discontinues tibulizumab development in hidradenitis suppurativa after Phase II miss
Onchilles reports early systemic activity with intratumoral N17350 in Phase I/II trial
Spruce separates CRHX-101 programme into new endocrinology company Adrenyx Biosciences
Read All Headlines
Upcoming Webinars
View All Upcoming WebinarsPast Webinars
Vaccine Development & its Manufacturing using Integrated High Throughput Technology
Presented by Dr. S.K. Jana, Director - R&D and Manufacturing, Human Vaccine Development, Serum Institute of India Pvt. Ltd. and Vikas Revankar, Head of Product Management and Marketing - Digital Portfolio, BioContinuum™ Platform - Merck and Piergiuseppe Nestola, PhD Global Vaccine Technology Consultant at Sartorius
20th September 2021
Validation Of Endotoxin Testing For CAR T-cell Manufacturing Quality Control & Benefits of Cartridge Technology
Presented by Dr. Zlatibor Velickovic PhD Production Manager | Department of Cell & Molecular Therapies, Royal Prince Alfred Hospital Sydney, Australia, ISCT Regional Vice-President Elect, Australia & New Zealand and Alan Hoffmeister Senior Global Technology & Market Development Manager, Charles River Laboratories
28th October 2021
Viral Safety by Design for Cell and Gene Therapy Products
Presented by Mark Plavsic, Chief Technology Officer at Lysogene and Dr. Magali Roche, Sales Manager, PathoQuest, Biologics Genomic Service
16th October 2020
View All Past Webinars
Featured Companies
View All Companies
Featured Video
At Pall we help you select the process model that’s perfect for you. Ensuring it’s adapted to meet your precise needs and assembled flawlessly, ready for the future, from day one.
View All Videos
Technical Papers
Strategy Emerging Markets for Risk Mitigation
Lifetime study for JSR Amsphere A3 – protein A resin
Caustic Stability of Amsphere A3 : Cycling Study with 0.5 M NaOH
Read All Technical Papers
Featured Products
Decrease Cleaning Validation Time and Resources
AdvantaPure
Amsphere™ A3 Protein A Resin – JSR Life Sciences
View All Products
